Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.

about

Age-associated physiological and pathological changes at the blood-brain barrier: A review.

P2860

Q39005977-C251FD79-43BB-4494-AFEB-241F5E1964EF

P2860

Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.

Item

http://www.wikidata.org/entity/Q48956010

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Permeability of blood-brain ba ...... ine-induced Parkinson disease.

@en

Permeability of blood-brain ba ...... ine-induced Parkinson disease.

@nl

type

Item

label

Permeability of blood-brain ba ...... ine-induced Parkinson disease.

@en

Permeability of blood-brain ba ...... ine-induced Parkinson disease.

@nl

prefLabel

Permeability of blood-brain ba ...... ine-induced Parkinson disease.

@en

Permeability of blood-brain ba ...... ine-induced Parkinson disease.

@nl

P1476

Permeability of blood-brain ba ...... ine-induced Parkinson disease.

@en

P2093

Caisheng Wu

http://www.w3.org/2001/XMLSchema#string

Hugues Contamin

http://www.w3.org/2001/XMLSchema#string

Jinlan Zhang

http://www.w3.org/2001/XMLSchema#string

Qin Li

http://www.w3.org/2001/XMLSchema#string

Thibaud Thiollier

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer Disease in the US Population

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

Amyloid plaque core protein in Alzheimer disease and Down syndrome

The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studies

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease

Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys

Blood-brain barrier alterations in ageing and dementia

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

P304

231-239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SYN.21889

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Erwan Bezard

P577

2016-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26799359

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

blood–brain barrier

Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.

about

P2860

P2860

Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921